DUSA Pharmaceuticals, Inc: Highlights
Financial data in U.S. dollars
| Financial Highlights |
|---|
| Sales |
28.81 Mil |
| Income |
-4.87 Mil |
| Net Profit Margin |
-16.89% |
| Return on Equity |
-28.37% |
| Debt/Equity Ratio |
0.00 |
|
| Revenue/Share |
1.20 |
| Earnings/Share |
-0.20 |
| Book Value/Share |
0.64 |
| Dividend Rate |
0.00 |
| Payout Ratio |
NA |
|
| Revenue - Quarterly Results (in Millions) |
|---|
| | FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | 7.1 | 7.9 | 6.7 |
| 2nd Qtr | 7.0 | 8.1 | 6.9 |
| 3rd Qtr | 6.9 | 5.7 | 5.8 |
| 4th Qtr | NA | 7.8 | 8.3 |
| Total | 21.0 | 29.5 | 27.7 |
| Earnings Per Share - Quarterly Results |
|---|
| | FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | -$0.07 | -$0.05 | -$0.17 |
| 2nd Qtr | -$0.04 | -$0.01 | -$0.13 |
| 3rd Qtr | -$0.02 | -$0.12 | -$0.10 |
| 4th Qtr | NA | -$0.08 | -$0.31 |
| Total | -$0.13 | -$0.26 | -$0.71 |
| Qtr. over Qtr. EPS Growth Rate |
| FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | 12% | 84% | --- |
| 2nd Qtr | 43% | 80% | 24% |
| 3rd Qtr | 50% | -1,100% | 23% |
| 4th Qtr | NA | 33% | -210% |
| Yr. over Yr. EPS Growth Rate |
| FY (12/09) | FY (12/08) |
|---|
| 1st Qtr | -40% | 71% |
| 2nd Qtr | -300% | 92% |
| 3rd Qtr | 83% | -20% |
| 4th Qtr | NA | 74% |
advertisement
Recent News